Full Text
The Full Text of this article is available as a PDF (273.8 KB).
References
- 1. Braunwald E: Unstable angina. An etiologic approach to management. Circulation 1998; 2219–2222 [DOI] [PubMed]
- 2. Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, Kastrati A, Schomig A: Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction. Circulation 1998; 98: 2695–2701 [DOI] [PubMed] [Google Scholar]
- 1. Braunwald E, Maseri A, Armstrong PW, Califf RM, Gibler WB, Hamm CW, Simoons ML, Van de Werf F: Rationale and clinical evidence for the use of GPIIb/IIIa inhibitors in acute coronary symptoms. Am Heart J 1998; 135 (suppl): S56–S66 [DOI] [PubMed] [Google Scholar]
- 2. Ronner E, Dykun Y, Van Den Brand MJBM, Van Den Wieken LR, Simmons ML: Platelet glycoprotein IIb/IIIa receptor antagonists. Eur Heart J 1998; 19: 1608–1616 [DOI] [PubMed] [Google Scholar]
- 3. Madan M, Berkowitz SD, Tcheng JE: Glycoprotein IIb/IIa integrin blockade. Circulation 1998; 98: 2629–2635 [DOI] [PubMed] [Google Scholar]
- 4. Kong DF: Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation 1998; 2829–2835 [DOI] [PubMed]